Häufigkeit thromboembolischer Komplikationen bei Patienten mit Lungenkarzinom
Catharina Crolow(Helios Klinikum Emil von Behring), W Grüning, Nicolas Schönfeld(Helios Klinikum Emil von Behring), Jens Kollmeier(Helios Klinikum Emil von Behring), R. Bittner(Marienhospital Stuttgart), Jürgen Behr(Ludwig-Maximilians-Universität München), Torsten Blum(MSB Medical School Berlin), Markus Samulowski(Helios Klinikum Emil von Behring), Torsten Bauer(Helios Klinikum Emil von Behring)
Cited by 0
Related Papers
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
|The Lancet Respiratory Medicine|2021|523
MultiLoc: prediction of protein subcellular localization using N-terminal targeting sequences, sequence motifs and amino acid composition
|Bioinformatics|2006|331
MultiLoc2: integrating phylogeny and Gene Ontology terms improves subcellular protein localization prediction
|BMC Bioinformatics|2009|316
Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
|European Respiratory Journal|2006|289